IRIS
PAGLIARULO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.551
EU - Europa 2.055
AS - Asia 2.020
SA - Sud America 546
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 70
OC - Oceania 5
Totale 10.382
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.376
SG - Singapore 849
IT - Italia 802
CN - Cina 429
BR - Brasile 422
HK - Hong Kong 266
SE - Svezia 251
DE - Germania 222
RU - Federazione Russa 182
VN - Vietnam 135
UA - Ucraina 131
FR - Francia 126
FI - Finlandia 101
GB - Regno Unito 92
IN - India 71
CA - Canada 65
BD - Bangladesh 40
AR - Argentina 33
IL - Israele 32
ID - Indonesia 27
BE - Belgio 22
MX - Messico 21
VE - Venezuela 20
ES - Italia 19
IQ - Iraq 19
PL - Polonia 19
ZA - Sudafrica 19
EC - Ecuador 18
JP - Giappone 18
IE - Irlanda 17
CO - Colombia 16
PK - Pakistan 16
SA - Arabia Saudita 16
TR - Turchia 16
CL - Cile 14
NI - Nicaragua 14
CI - Costa d'Avorio 13
CR - Costa Rica 13
CW - ???statistics.table.value.countryCode.CW??? 12
MA - Marocco 11
MY - Malesia 11
PH - Filippine 11
PY - Paraguay 11
LT - Lituania 10
SV - El Salvador 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
GP - Guadalupe 9
HN - Honduras 9
NL - Olanda 9
AE - Emirati Arabi Uniti 8
GT - Guatemala 7
NP - Nepal 7
TN - Tunisia 7
AT - Austria 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
PR - Porto Rico 5
PT - Portogallo 5
AU - Australia 4
BB - Barbados 4
DK - Danimarca 4
KG - Kirghizistan 4
LB - Libano 4
PS - Palestinian Territory 4
SC - Seychelles 4
AL - Albania 3
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
IR - Iran 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
MK - Macedonia 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
OM - Oman 2
TH - Thailandia 2
UY - Uruguay 2
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KZ - Kazakistan 1
LV - Lettonia 1
Totale 10.251
Salva come PNG Salva come JPEG
Città #
Ashburn 543
Fairfield 461
Singapore 425
Woodbridge 397
San Jose 380
Chandler 331
Jacksonville 303
Houston 295
Hong Kong 265
Milan 207
Seattle 202
Nyköping 187
Ann Arbor 177
Cambridge 161
Wilmington 161
Council Bluffs 129
Beijing 117
Rome 78
Roxbury 75
Lauterbourg 74
Lawrence 73
Dallas 69
Nanjing 67
Los Angeles 66
Inglewood 59
Santa Clara 54
São Paulo 52
New York 50
Boardman 49
Des Moines 44
Ho Chi Minh City 42
Columbus 36
Brooklyn 29
Buffalo 29
Hanoi 28
Helsinki 27
Atlanta 25
Bari 25
Princeton 25
Brussels 21
Tel Aviv 21
Warsaw 19
Bologna 18
Hebei 18
Dublin 17
Munich 17
Nanchang 17
Tokyo 17
Changsha 16
Falkenstein 16
Frankfurt am Main 16
Jiaxing 16
Moscow 16
Naples 16
Figino 15
Phoenix 15
Toronto 15
London 14
Abidjan 13
Managua 13
San Francisco 13
Shenyang 13
Chicago 12
Denver 12
Johannesburg 12
North Bergen 12
Willemstad 12
Dearborn 11
Florence 11
Montreal 11
Belo Horizonte 10
Boston 10
Brasília 10
Da Nang 10
Paris 10
Tianjin 10
Baghdad 9
Orem 9
Poplar 9
San José 9
Tashkent 9
Brno 8
Osasco 8
San Diego 8
San Salvador 8
The Dalles 8
Caracas 7
Chennai 7
Guatemala City 7
Lahore 7
Manchester 7
Mexico City 7
Quito 7
Rio de Janeiro 7
Shanghai 7
Curitiba 6
Delhi 6
Guangzhou 6
Haiphong 6
Miami 6
Totale 6.520
Salva come PNG Salva come JPEG
Nome #
Linfadenectomia iliaco-otturatoria: quando e perchè 384
Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins 235
Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay 187
Antiproliferative activity evaluation of a series of N-1,3-benzothiazol-2-ylbenzamides as novel apoptosis inducers 173
The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line 168
Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era. 163
Correlation between sigma2 receptor protein expression and histopathologic grade in human bladder cancer 163
Celecoxib for the treatment of non muscle invasive bladder cancer. Results from the first phase II clinical trial 158
A CONCISE 4-GENE PANEL CAN PREDICT CLINICAL OUTCOME IN URINARY BLADDER CANCER 156
Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer 153
Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer 150
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study 144
Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study 140
Contrast-enhanced multislice pneumo-CT-cystography in the evaluation of urinary bladder neoplasms 140
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 139
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 137
Role of genetic and expression profiling in pharmacogenomics: the changing face of patient management. 135
A COMPARISON OF HAND-SEWN AND STA PLED W ILEAL RESERVOIR FOR ORTHOTO PIC BLADER REPLACEMENT 131
Surgical treatment of a rare case of epithelioid hemangioendothelioma of the azygos vein 131
Significance of occult metastases to the lymph nodes in patients with prostate cancer. Results from a long term follow up study 130
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer 130
AGE AND STAGE AS PREDICTIVE FACTORS FOR A ORTHOTO PIC NEOBLADER AFTER RADICAL CYSTECTOMY: RESULTS ON 290 CASES. AGILE GROUP EXPERIENCE 128
RE-TREATMENT WITH DOCETAXEL IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (CRPC) 124
Molecular changes of malignant mesothelioma in the testis and their impact on prognosis: Analyses of two cases 124
Celecoxib for the prevention of nonmuscle invasive bladder cancer: Results from a matched control study 122
Approccio multi-target alla terapia medica dell’ipertrofia prostatica benigna 117
Adenocarcinoma della prostate stadio pN0: ruolo delle metastasi occulte 115
Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis 114
“Neoplasie uroteliali della vescica.” 114
Biopsia prostatica, quanti prelievi?: la nostra proposta 114
A multi-center retrospective study of single-port versus multi-port video-assisted thoracoscopic lobectomy and anatomic segmentectomy 112
Reply to Erik B. Cornel's Letter to the Editor re: Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger, et al. Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol 2012;61:11-25 111
Contemporary urologic minilaparoscopy: Indications, techniques, and surgical outcomes in a multi-institutional European cohort 109
an observational prospective evaluation of 3-mm transperitoneal laparoscopic pyeloplasty. Feasibility and functional results 107
THE INTERACTION OF CELECOXIB WITH MDR TRANSPORTERS ENHANCES THE ACTIVITY OF MITOMYCIN C IN A BLADDER CANCER CELL LINE 107
Biological screening of new 2-mercaptobenzothiazole derivatives for the treatment of prostate cancer 107
Malignant mesothelioma of the tunica-vaginalis: one case report studied by microarray-comparative hybridization (a-CGH) 106
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up. 106
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study 105
Ruolo dell’endoscopia a fluorescenza nei carcinomi uroteliali non muscolo-infiltranti e ad alto rischio della vescica. Studio osservazionale, prospettico, multicentrico 105
DETECTION AND CLINICAL SIGNIFICANCE OF OCCULT LYMPH NODE METASTASES AND CIRCULATING CANCER CELLS IN PATIENTS WITH INVASIVE BLADDER CANCER 105
Farmacocinetica, stabilità, tollerabilità e attività della MMC somministrata tramite un nuovo dispositivo per ipertermia (UniThermia®) in pazienti “BCG failures” 102
Sigma-2 receptors as potential novel biomarkers during the progression of benign prostatic hypertrophy (BPH) into prostate cancer 100
Ruolo dell’ESWL nelle urgenze della litiasi ureterale 99
Androgen deprivation therapy for prostate cancer 99
Quantitative transcriptional profilino of cell survival and cell death genes in cultured bladder cancer cells 95
Athermal versus ultrasonic nerve-sparing laparoscopic radical prostatectomy: a comparison of functional and oncological outcomes 94
Xi Nerve-sparing Robotic Radical Perineal Prostatectomy: European Single-center Technique and Outcomes 94
PCR Competitiva Standardizzata per la caratterizzazione molecolare di quattro linee cellulari vescicali 92
Linfoadenectomia retroperitoneale video-laparoscopica mediante accesso transperitoneale 92
The accuracy of fluorescence cystoscopy in a cohort of patients undergoing radical cystectomy 92
COMBINED LIDOCAINE-PRILOCAINE CREAM AND LIDOCAINE-KETOROLAC GEL PROVIDE BETTER PAIN RELIEF THAN COMBINED LIDOCAINE-PRILOCAINE CREAM AND PERIPROSTATIC NERVE BLOCK DURING TRANSRECTAL PROSTATE BIOPSY 91
Prerectal-transperineal approach for treatment of recurrent vesico-urethral anastomotic stenosis after radical prostatectomy 89
Generation of a concise gene panel for outcome prediction in urinary bladder cancer 88
Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR 87
The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial. 87
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer 85
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer 85
Diagnostic accuracy of hexaminolevulinate in a cohort of patients undergoing radical cystectomy 85
Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Transperineal Prostate Biopsy: Diagnostic Accuracy from a Single Center Retrospective Study 82
Noninfiltrative anesthesia for transrectal prostate biopsy: a randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 82
Correzione laparoscopica di malformazione del giunto pielo-ureterale utilizzando strumentazione da 3mm 82
null 81
null 81
STAT 3 activation in human bladder cancer 80
Evaluation of sigma2 receptor expression in human invasive bladder cancer 80
Human epididymal and prostate tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay 80
Metastasi Occulte In Linfonodi Pelvici Di Pazienti Sottoposti A Prostatectomia Radicale. Incidenza E Significato Prognostico Dopo 11 Anni Di Follow-Up Medio 80
Longer operative time and hospital stay are associated with postoperative cYstectomy complications: a modified Clavien classification system analysis 78
Severe systemic disease of the American Society of Anesthesiologists' (ASA) physical status system classification associated with delayed length of hospital stay in 1329 consecutive patients treated with radical prostatectomy for clinical prostate cancer 75
Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection 73
Molecular characterization of bladder cancer cell lines by quantitative transcript profiling using the StaRT PCR assay 73
Sexual dysfunction in patients under dialytic treatment 72
null 72
Entry techniques in laparoscopic radical and partial nephrectomy: A multicenter international survey of contemporary practices 72
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis 71
PROCEDURE MININVASIVE PER IL TRATTAMENTO DELLA IPERTROFIA PROSTATICA BENIGNA A CONFRONTO: ENUCLEAZIONE LASER VERSUS VAPORIZZAZIONE FOTOSELETTIVA 71
Neoplasie uroteliali della vescica 70
Nonmuscular Invasive Urothelial Carcinoma of the Bladder in Pediatric and Young Adult Patients: Age-related Outcomes 69
Intravesical electro-osmotic administration of mitomycin C 67
L’esame obiettivo 67
Prostatectomia Radicale Videolaparoscopica mediante l’uso del dispositivo Thunderbeat® 66
Neoplasie uroteliali della vescica 66
Modificazioni emoreologiche nei tumori della vescica 66
Sensitivity and reproducibility of Standardized Competitive RT PCR (StaRT PCR) for transcript quantification and its comparison with Taqman Real-time RT-PCR 65
Androgen deprivation therapy and cardiovascular risk in prostate cancer 64
null 64
null 64
Contrast-enhanced multislice pneumo-CT-cystography in the evaluation of urinary bladder neoplasms 63
Robotic “Side Hole” Technique Placement of Ureteral Stent for Ureteral Lesion 61
null 61
Prognostic role of chromogranin A expression for docetaxel response in hormone-refractory metastatic prostate cancer 58
Ectopic adrenal tissue in the kidney: A systematic review 57
Prognostic factors and clinical outcome in patients with surgically resected peripheral N0 adenocarcinoma <3 cm 55
null 54
The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection 52
null 52
Urothelial carcinoma of the prostatic urethra: Long-term follow-up study 51
null 51
Correlation between human epidermal growth factor receptor 2 (HER2) status and central nervous system (CNS) involvement in metastatic castration-resistant prostate cancer (mCRPC) 50
Totale 10.133
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022402 0 0 0 0 26 59 15 23 34 28 112 105
2022/2023898 117 87 62 82 120 119 6 115 160 9 9 12
2023/2024278 34 46 9 22 22 44 2 12 2 10 5 70
2024/20251.351 57 20 107 51 44 98 107 117 62 61 206 421
2025/20263.105 411 186 188 331 306 168 348 95 291 285 100 396
2026/2027948 128 173 233 398 16 0 0 0 0 0 0 0
Totale 10.382